4
Changes in Ownership
Altimmune, Inc. Filed Acc 0001012975-18-000457
Chief Scientific Officer acquired 55,120 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Roberts M Scot · Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-05-21 | Exercise or conversion : show line 1 in the form | +55,120 | $0.08 | $4,410 | 55,120 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-05-21 | Grant or award : show line 2 in the form Stock Options (option to buy) | +50,016 | 50,016 | D |
| 2018-05-21 | Exercise or conversion : show line 3 in the form Stock Options (option to buy) | −55,120 | 0 | D |
Loading xslF345X03/edgar.xml…